Extended-spectrum beta-lactamase inhibitors

All categories
DBCAT005905Pharmacologic class

A DrugBank category of 2 drugs. 2 of them are approved.

Part of
beta-Lactamase Inhibitors
Drugs

What you can answer from here — as of February 27, 2024

2DrugsEach linked to its full drug card
Listed above
7Drug targetsEvery drug–target pair in the class, with bond type
Sign in
3Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
1Route of administrationHow the drugs in this class are given
Sign in

Which targets do Extended-spectrum beta-lactamase inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In